Wall Street firms Blackstone, KKR, TPG and General Atlantic have poured $10 billion into Indian hospital chains over the past five years, with KKR paying $1.4 billion for Medicover’s Indian arm in August 2024 and earlier investing in Baby Memorial Hospital in Kerala, boosting its pre‑tax earnings to 6 billion rupees by fiscal 2026.
The capital is fueling bed expansions, high‑tech purchases and cross‑merger deals that lift a hospital’s revenue per occupied bed. India has 1.3 beds per 1,000 people, a figure that falls short of many developed economies.
Medical inflation has surged to 13% annually, and private facilities charge five to ten times what public hospitals do, especially in cancer, cardiac, kidney and maternity care – a reality that critics say hurts patients.
Joseph Benaven, managing director of Kanate Hospitals, said the industry’s focus has shifted from operating rooms to boardrooms, where return on capital and revenue per occupied bed become the new metrics.
A parliamentary committee in August warned that an unchecked influx of foreign capital was fueling cost‑driven acquisitions, and called for a review of foreign‑investment rules and price caps, a recommendation that the cabinet will examine in September.